MTOR and prostate carcinoma: Hsa-mir-99a-5p enhanced the radiation sensitivity of non-small cell lung cancer by targeting mTOR, and inhibition of the glucocorticoid receptor resulted in an enhanced hsa-mir-99a-5p-mediated radiation response in stem-like cells from human prostate cancers [12, 13].